DCGO earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Buy, P/E -0.35. Updated 2026-07-23.
DocGo (DCGO) Research Hub
DocGo (DCGO) trades on NASDAQ, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-09-11, shares last closed at 0.3523 USD (-4.78%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.35, market cap 0.07B. This hub links to the full technical, earnings and options research available for DCGO.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.3523 USD (-4.78%) |
| 52-week range | 0.3451 USD – 0.7196 USD |
| Trend regime | Range |
| 14-day RSI | 27.9 (Oversold) |
| Trailing P/E | -0.35 |
| Market cap | 0.07B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for DCGO
Covered Call on DCGO: how it works, illustrative setup around the real 0.3523 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DCGO: how it works, illustrative setup around the real 0.3523 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DCGO: how it works, illustrative setup around the real 0.3523 USD price, max profit/loss, breakeven and when to use it. Educational.
DCGO technical analysis: range, last 0.3523 USD, RSI 27.9, 52w range 0.3451 USD–0.7196 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is DCGO in?
DocGo (DCGO) is classified under Healthcare (Medical - Care Facilities), listed on NASDAQ, US.
Is DCGO in an uptrend or downtrend?
As of 2026-09-11, DCGO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DCGO's trailing P/E ratio?
DCGO's trailing P/E is -0.35, with a market cap of 0.07B. See the earnings research page for full valuation detail.
When does DCGO next report earnings?
DCGO is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.0975 USD.